Januvia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Cognitive Protective Effect of Newer Antidiabetic Drugs
Condition:   Type 2 Diabetes Interventions:   Drug: Dapagliflozin;   Drug: Empagliflozin;   Drug: Canagliflozin;   Drug: Sitagliptin;   Drug: Saxagliptin;   Drug: Linagliptin;   Drug: Vildagliptin Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components
Condition:   Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus) Interventions:   Drug: Dapagliflozin/sitagliptin FDC;   Drug: Sitagliptin;   Drug: Dapagliflozin Sponsors:   AstraZeneca;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials